A Confirmatory Clinical Trial of Two-fractionated Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Prostate Cancer Patients - Trial UMIN000049746
Access comprehensive clinical trial information for UMIN000049746 through Pure Global AI's free database. This Phase 2 trial is sponsored by National Cancer Center and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
UMIN000049746
Phase 2
Recruiting
Device Trial
device
Trial Details
University Hospital Medical Information Network • UMIN000049746
A Confirmatory Clinical Trial of Two-fractionated Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Prostate Cancer Patients
Study Focus
Sponsor & Location
National Cancer Center
Japan
Timeline & Enrollment
Phase 2
Jan 01, 2023
N/A
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
University Hospital Medical Information Network
UMIN000049746
Device Trial